MabSpace Biosciences

MabSpace Biosciences

MabSpace Biosciences

MabSpace Biosciences, is a biotech company focused on discovery and development of innovative antibody based therapeutics for cancer and fibrotic diseases.
Founded
2011
Raised
$40M
Follow us
Alexa global traffic share
Latest funding
$40,000,000
Venture capital (Series B) - 2018
Lilly Asia Ventures Sequoia Capital China King Star
Team Size
1–10
Employees
Location
Headquarters
$40,000,000 Venture capital (Series B)
ChinaMoneyNetwork , AVCJ

DealShot: Sequoia Capital Lead $40M Series B Round In China's MabSpace Biosciences